Technique and Not Preoperative Factors Determine Ross Outcomes

The Ross procedure is undergoing a renaissance in adult cardiac surgery as data accumulates that it represents the best available aortic valve substitute for nonrepairable valves. 1 El-Hamamsy I. Toyoda N. Itagaki S. et al. Propensity-matched comparison of the Ross procedure and prosthetic aortic valve replacement in adults. J Am Coll Cardiol. 2022; 79: 805-815 Crossref PubMed Scopus (28) Google Scholar No valve is free from valve-related complications, but late reoperation, as is sometimes needed after the Ross procedure, appears to be less lethal than anticoagulation-associated stroke/thromboembolism (mechanical prosthesis) and the excess mortality of biologic prosthesis in younger patients (<60 years). The survival advantage of the Ross procedure is predicated on excellent results. 2 Yacoub M.H. El-Hamamsy I. Sievers H.H. et al. Under-use of the Ross operation—a lost opportunity. Lancet. 2014; 384: 559-560 Abstract Full Text Full Text PDF PubMed Scopus (52) Google Scholar ,3 Stelzer P. Mejia J. Varghese R. Operative risks of the Ross procedure. J Thorac Cardiovasc Surg. 2021; 161: 905-915 Abstract Full Text Full Text PDF PubMed Scopus (6) Google Scholar Unicuspid Aortic Valve in Patients Undergoing the Ross ProcedureThe Annals of Thoracic SurgeryVol. 115Issue 3PreviewThe prevalence and outcomes of the unicuspid aortic valve (UAV) in patients undergoing the Ross procedure have been strongly underreported in the current literature. We sought to evaluate this in comparison with bicuspid (BAV) and tricuspid valve (TAV) in our Ross cohort. Full-Text PDF